Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 3/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | AKT2 | P31751 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2634662 | 0.83 | NUDT1 (0.61) | NUDT1CCNA2CDK2 | |
| SCHEMBL16513136 | 0.79 | NUDT1 (0.44) | NUDT1ADORA3ADORA2AADORA1CCNA2 | |
| SCHEMBL27481634 | 0.79 | NUDT1 (0.44) | NUDT1ADORA3ADORA2AADORA1CCNA2 | |
| SCHEMBL28290898 | 0.79 | NPY5R (0.36) | NUDT1ADORA3NPY5RADORA2AADORA1 | |
| SCHEMBL9797844 | 0.77 | NUDT1 (0.41) | NUDT1ADORA3ADORA2AADORA1CCNA2 | |
| SCHEMBL1059581 | 0.72 | NUDT1 (0.68) | NUDT1ADORA2AADORA1ALDH1A1AKT2 | |
| SCHEMBL14427981 | 0.71 | NUDT1 (0.37) | NUDT1ADORA3ADORA2AADORA1CSNK2A1 | |
| SCHEMBL16513129 | 0.70 | POLB (0.41) | NUDT1ADORA3ADORA1ALDH1A1L3MBTL1 | |
| SCHEMBL1290911 | 0.70 | NUDT1 (0.61) | NUDT1ADORA3ADORA2AADORA1CCNA2 | |
| SCHEMBL9797826 | 0.69 | NUDT1 (0.36) | NUDT1ADORA3ADORA2AADORA1CSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-20250129308-A1 | SEMICONDUCTOR TREATMENT LIQUID, TREATMENT METHOD FOR OBJECT TO BE TREATED, AND MANUFACTURING METHOD OF ELECTRONIC DEVICE | FUJIFILM CORP (JP) | 2025-04-24 | — | — | US | claimed |
| CN-119404296-A | Semiconductor processing liquid, method for processing object to be processed, and method for manufacturing electronic device | 富士胶片株式会社 | 2025-02-07 | — | — | CN | claimed |
| WO-2024233308-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | ORNA THERAPEUTICS, INC. (US) | 2024-11-14 | — | — | WO | claimed |
| WO-2024014224-A1 | SEMICONDUCTOR PROCESSING LIQUID, METHOD FOR PROCESSING OBJECT TO BE PROCESSED, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | 富士フイルム株式会社 | 2024-01-18 | — | — | WO | claimed |
| CN-111741967-A | Nucleoside analogue, preparation method and application | 深圳市真迈生物科技有限公司 | 2020-10-02 | — | — | CN | claimed |
| CN-106967068-A | N6The photochemistry demethyl method of methyl adenine | 中国科学院化学研究所 | 2017-07-21 | — | — | CN | claimed |
| WO-2016126987-A1 | COMPOSITIONS AND METHODS FOR SYNTHETIC GENE ASSEMBLY | Twist Bioscience Corporation (US) | 2016-08-11 | — | — | WO | claimed |
| EP-2694524-A1 | 2'-O-AMINOOXYMETHYL NUCLEOSIDE DERIVATIVES FOR USE IN THE SYNTHESIS AND MODIFICATION OF NUCLEOSIDES, NUCLEOTIDES AND OLIGONUCLEOTIDES | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) | 2014-02-12 | — | — | EP | claimed |
| EP-2547769-A1 | MINOR GROOVE BINDER (MGB)-OLIGONUCLEOTIDE MIRNA ANTAGONISTS | Elitech Holding B.V. (NL) | 2013-01-23 | — | — | EP | claimed |
| WO-2012138530-A1 | 2'-O-AMINOOXYMETHYL NUCLEOSIDE DERIVATIVES FOR USE IN THE SYNTHESIS AND MODIFICATION OF NUCLEOSIDES, NUCLEOTIDES AND OLIGONUCLEOTIDES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-10-11 | — | — | WO | claimed |
| WO-2011066312-A1 | MINOR GROOVE BINDER (MGB)-OLIGONUCLEOTIDE MIRNA ANTAGONISTS | ELITECH HOLDING B.V. (NL) | 2011-06-03 | — | — | WO | claimed |
| WO-2026103877-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | 中生复诺健生物科技(上海)有限公司 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026106956-A1 | DISULFIDE-STABILIZED NOROVIRUS VIRUS-LIKE PARTICLE DESIGN | MERCK SHARP & DOHME LLC (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-4743437-A1 | DIESTER LIPIDS, LIPID NANOPARTICLE CONTAINING DIESTER LIPIDS, AND FORMULATIONS THEREOF | Providence Therapeutics Holdings Inc. (CA) | 2026-05-20 | — | — | EP | disclosed |
| CN-122038302-A | Modified T cells and methods of making and using the same | 哈佛学院校长同事会 | 2026-05-15 | — | — | CN | disclosed |
| EP-0155911-A1 | Purine derivatives for the regulation of plant growth | CIBA-GEIGY AG (CH) | 1985-09-25 | — | — | EP | disclosed |
| US-4543388-A | Thermosettable polymers or prepolymers prepared from polymethylated pyrazines and aromatic polyaldehydes and cured products therefrom | THE DOW CHEMICAL COMPANY (US) | 1985-09-24 | — | — | US | disclosed |
| EP-0147689-A2 | A method of inducing antitumor immunocytes, and a process for producing antitumor immunocytes and antitumor immunocytes produced by the process | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1985-07-10 | — | — | EP | disclosed |
| US-4376823-A | RNA, ANTIBIOTIC RESISTANCE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1983-03-15 | — | — | US | disclosed |